Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Changing Landscape of Maintenance Therapy in Newly Diagnosed Multiple Myeloma: A Systematic Review With Network Meta-Analysis of the European Myeloma Network (EMN).

American journal of hematology·2026
Same author

Evaluating the Real-World Value of Daratumumab Addition to Multiple Myeloma Induction Therapy by Real-World Minimal Residual Disease Assessment and Extended Genetic Profiling.

Clinical lymphoma, myeloma & leukemia·2025
Same author

Machine learning risk stratification strategy for multiple myeloma: Insights from the EMN-HARMONY Alliance platform.

HemaSphere·2025
Same author

The risk of second primary malignancies in patients receiving T-cell directed therapies for multiple myeloma: a systematic review.

Leukemia & lymphoma·2025
Same author

A response to EA-4/23 INF:2025 "The Assessment and Accreditation of Opinions and Interpretations using ISO/IEC 17025:2017".

Forensic science international·2025
Same author

Symptomatic progression-free survival as an emerging patient-centered endpoint in multiple myeloma: a secondary analysis of MagnetsiMM-3 trial data.

BMC cancer·2025
Same journal

Intrinsic capacity and the trajectory of ischemic heart disease and its complications: the mediating role of insulin resistance indices.

Maturitas·2026
Same journal

Mobility limitation trajectories and longitudinal changes in delayed recall in midlife and later life: A multicohort study.

Maturitas·2026
Same journal

Digital twins in menopause: a roadmap for integrating endocrine dynamics, multisystem physiology, and precision medicine.

Maturitas·2026
Same journal

Testosterone therapy in women: Keeping pace with the evidence.

Maturitas·2026
Same journal

Diagnosis and management of androgen excess presenting after menopause.

Maturitas·2026
Same journal

Domain-specific severity of menopausal symptoms and emotional eating in midlife women.

Maturitas·2026
See all related articles

Related Experiment Videos

Erectile dysfunction and coronary disease: evaluating the link.

Graham Jackson1

  • 1Guy's and St Thomas' Hospitals NHS Trust, United Kingdom. gjcardiol@talk21.com

Maturitas
|April 17, 2012
PubMed
Summary
This summary is machine-generated.

Erectile dysfunction (ED), a common vascular condition, often signals future cardiovascular events. Early detection of ED in men can lead to timely cardiovascular risk reduction and potentially prevent early death.

Related Experiment Videos

Area of Science:

  • Cardiology
  • Urology
  • Men's Health

Background:

  • Erectile dysfunction (ED) affects a significant portion of aging men, with prevalence increasing with age.
  • ED is primarily a vascular condition and frequently precedes major cardiovascular events by 3-5 years.
  • ED is linked to increased risks of acute coronary syndromes, cardiovascular mortality, and all-cause mortality.

Purpose of the Study:

  • To highlight the significance of erectile dysfunction as an early indicator of cardiovascular disease.
  • To emphasize the importance of integrating ED screening into routine healthcare for cardiovascular risk assessment.
  • To underscore the impact of ED on quality of life and relationships, and the success of its treatment.

Main Methods:

  • This abstract is based on a review of existing literature and clinical observations regarding erectile dysfunction and cardiovascular health.
  • The focus is on the epidemiological data, clinical associations, and implications for patient care.
  • No specific new experimental methods were employed; it synthesizes current knowledge.

Main Results:

  • Erectile dysfunction is a prevalent condition, affecting 40% of men over 40 and one in three men over 70.
  • ED serves as an important early warning sign for underlying vascular disease and future cardiovascular events.
  • Early identification of ED provides a critical opportunity for cardiovascular risk reduction.

Conclusions:

  • Erectile dysfunction is a significant health issue with profound implications for cardiovascular health and overall mortality.
  • Routine inquiry about ED in patient care is crucial for early detection of cardiovascular risks.
  • Effective treatments for ED can maintain quality of life for affected individuals, particularly in middle-aged and elderly populations.